Last 12 months
Inside the activity.
0 purchase rows · 6 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 13, 2018 Filed Jun 15, 2018 17:47 UTC |
GLUCK FREDERICK WDirector
|
GrantStock Option (Right to Buy) · Derivative | 14,000 | $0.00 Strike: $25.25 | $0.00 |
DisclosureSEC source: 0000899243-18-016816 · doc4.xml · derivative · entry 4 GLUCK FREDERICK W · CIK 0001184126 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2028-06-12 F3 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2019 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date. Read SEC document |
| June 13, 2018 Filed Jun 15, 2018 21:52 UTC |
Fuchs Charles S.Director
|
GrantStock Option (Right to Buy) · Derivative | 14,000 | $0.00 Strike: $25.25 | $0.00 |
DisclosureSEC source: 0000899243-18-016824 · doc4.xml · derivative · entry 1 Fuchs Charles S. · CIK 0001719576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2028-06-12 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2019 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date. Read SEC document |
| June 13, 2018 Filed Jun 15, 2018 21:49 UTC |
Young Matthew P.Director
|
GrantStock Option (Right to Buy) · Derivative | 14,000 | $0.00 Strike: $25.25 | $0.00 |
DisclosureSEC source: 0000899243-18-016820 · doc4.xml · derivative · entry 1 Young Matthew P. · CIK 0001601583 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2028-06-12 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2019 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date. Read SEC document |
| June 01, 2018 Filed Jun 5, 2018 23:46 UTC |
RAY DEBANJANChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $1.26 | $0.00 |
DisclosureSEC source: 0001140361-18-027475 · doc1.xml · derivative · entry 4 RAY DEBANJAN · CIK 0001706863 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,710 Underlying: Common Stock · 3,000 shares Expires 2023-12-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F4 · derivative.exercise_date: 100% of the shares subject to the option are fully vested and exercisable. Read SEC document |
| June 01, 2018 Filed Jun 5, 2018 23:46 UTC |
RAY DEBANJANChief Financial Officer
|
SaleCommon Stock | 3,000 | $25.93 | $77,793.00 |
DisclosureSEC source: 0001140361-18-027475 · doc1.xml · nonDerivative · entry 3 RAY DEBANJAN · CIK 0001706863 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,928 F2 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F3 · price: This transaction was executed in multiple trades in prices ranging from $25.75 to $26.25, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F1 · balance_after: The shares were acquired under the issuer's Employee Stock Purchase Plan on May 31, 2018. Read SEC document |
| June 01, 2018 Filed Jun 5, 2018 23:46 UTC |
RAY DEBANJANChief Financial Officer
|
Exercise / conversionCommon Stock | 3,000 | $1.26 | $3,779.70 |
DisclosureSEC source: 0001140361-18-027475 · doc1.xml · nonDerivative · entry 2 RAY DEBANJAN · CIK 0001706863 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,928 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. Read SEC document |
| May 31, 2018 Filed Jun 5, 2018 23:46 UTC |
RAY DEBANJANChief Financial Officer
|
GrantCommon Stock | 1,187 | $17.90 | $21,248.49 |
DisclosureSEC source: 0001140361-18-027475 · doc1.xml · nonDerivative · entry 1 RAY DEBANJAN · CIK 0001706863 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,928 F1 · shares: The shares were acquired under the issuer's Employee Stock Purchase Plan on May 31, 2018. Read SEC document |
| May 31, 2018 Filed Jun 5, 2018 23:45 UTC |
McCarthy Sean A.Director · President and CEO
|
GrantCommon Stock | 302 | $17.90 | $5,406.10 |
DisclosureSEC source: 0001140361-18-027474 · doc1.xml · nonDerivative · entry 1 McCarthy Sean A. · CIK 0001654058 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,945 F1 · shares: The shares were acquired under the issuer's Employee Stock Purchase Plan on May 31, 2018. Read SEC document |
| May 01, 2018 Filed May 2, 2018 22:26 UTC |
RAY DEBANJANChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $1.26 | $0.00 |
DisclosureSEC source: 0001140361-18-021345 · doc1.xml · derivative · entry 3 RAY DEBANJAN · CIK 0001706863 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,710 Underlying: Common Stock · 3,000 shares Expires 2023-12-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F3 · derivative.exercise_date: 100% of the shares subject to the option are fully vested and exercisable. Read SEC document |
| May 01, 2018 Filed May 2, 2018 22:26 UTC |
RAY DEBANJANChief Financial Officer
|
SaleCommon Stock | 3,000 | $26.52 | $79,562.10 |
DisclosureSEC source: 0001140361-18-021345 · doc1.xml · nonDerivative · entry 2 RAY DEBANJAN · CIK 0001706863 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,741 F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades in prices ranging from $26.22 to $26.75, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| May 01, 2018 Filed May 2, 2018 22:26 UTC |
RAY DEBANJANChief Financial Officer
|
Exercise / conversionCommon Stock | 3,000 | $1.26 | $3,779.70 |
DisclosureSEC source: 0001140361-18-021345 · doc1.xml · nonDerivative · entry 1 RAY DEBANJAN · CIK 0001706863 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,741 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. Read SEC document |
| May 01, 2018 Filed May 2, 2018 22:25 UTC |
McCarthy Sean A.Director · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 19,578 | $0.00 Strike: $1.57 | $0.00 |
DisclosureSEC source: 0001140361-18-021344 · doc1.xml · derivative · entry 4 McCarthy Sean A. · CIK 0001654058 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,226 Underlying: Common Stock · 19,578 shares Expires 2025-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F4 · derivative.exercise_date: This option vests in 48 substantially equal monthly installments starting on the last day of January 2015 Read SEC document |
| May 01, 2018 Filed May 2, 2018 22:25 UTC |
McCarthy Sean A.Director · President and CEO
|
SaleCommon Stock | 19,578 | $26.55 | $519,743.04 |
DisclosureSEC source: 0001140361-18-021344 · doc1.xml · nonDerivative · entry 2 McCarthy Sean A. · CIK 0001654058 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,643 F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades in prices ranging from $26.22 to $26.77, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| May 01, 2018 Filed May 2, 2018 22:25 UTC |
McCarthy Sean A.Director · President and CEO
|
Exercise / conversionCommon Stock | 19,578 | $1.57 | $30,833.39 |
DisclosureSEC source: 0001140361-18-021344 · doc1.xml · nonDerivative · entry 1 McCarthy Sean A. · CIK 0001654058 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,221 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 18:27 UTC |
RAY DEBANJANChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $1.26 | $0.00 |
DisclosureSEC source: 0001140361-18-016993 · doc1.xml · derivative · entry 3 RAY DEBANJAN · CIK 0001706863 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,710 Underlying: Common Stock · 3,000 shares Expires 2023-12-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 100% of the shares subject to the option are fully vested and exercisable. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 18:27 UTC |
RAY DEBANJANChief Financial Officer
|
SaleCommon Stock | 3,000 | $28.12 | $84,360.00 |
DisclosureSEC source: 0001140361-18-016993 · doc1.xml · nonDerivative · entry 2 RAY DEBANJAN · CIK 0001706863 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,741 F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 18:27 UTC |
RAY DEBANJANChief Financial Officer
|
Exercise / conversionCommon Stock | 3,000 | $1.26 | $3,779.70 |
DisclosureSEC source: 0001140361-18-016993 · doc1.xml · nonDerivative · entry 1 RAY DEBANJAN · CIK 0001706863 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,741 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 26, 2018 Filed Mar 27, 2018 20:54 UTC |
GLUCK FREDERICK WDirector
|
SaleCommon Stock | 5,000 | $31.93 | $159,641.50 |
DisclosureSEC source: 0001140361-18-015300 · doc1.xml · nonDerivative · entry 1 GLUCK FREDERICK W · CIK 0001184126 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Frederick W. Gluck 1997 Family Trust dtd July 28, 1997 Disclosed balance after: 271,643 F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $31.70 to $32.18, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F3 · ownership.nature: The Reporting Person is a trustee of Frederick W. Gluck 1997 Family Trust dtd July 28, 1997. Read SEC document |
| March 02, 2018 Filed Mar 5, 2018 19:01 UTC |
GLUCK FREDERICK WDirector
|
SaleCommon Stock | 16,181 | $30.00 | $485,465.60 |
DisclosureSEC source: 0001140361-18-012114 · doc1.xml · nonDerivative · entry 1 GLUCK FREDERICK W · CIK 0001184126 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Frederick W. Gluck 1997 Family Trust dtd July 28, 1997 Disclosed balance after: 276,643 F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.09, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F3 · ownership.nature: The Reporting Person is a trustee of Frederick W. Gluck 1997 Family Trust dtd July 28, 1997. Read SEC document |
| March 02, 2018 Filed Mar 5, 2018 23:59 UTC |
HUMPHREY RACHELChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 16,160 | $0.00 Strike: $6.61 | $0.00 |
DisclosureSEC source: 0001140361-18-012113 · doc1.xml · derivative · entry 3 HUMPHREY RACHEL · CIK 0001579781 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,980 Underlying: Common Stock · 16,160 shares Expires 2025-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option vests 25% on August 28, 2016, and the remaining 75% vests in 36 substantially equal monthly installments thereafter, with each additional installment vesting on the last day of the month, except the final installment, which shall vest on August 28, 2019. Read SEC document |
| March 02, 2018 Filed Mar 5, 2018 23:59 UTC |
HUMPHREY RACHELChief Medical Officer
|
SaleCommon Stock | 16,160 | $30.00 | $484,800.00 |
DisclosureSEC source: 0001140361-18-012113 · doc1.xml · nonDerivative · entry 2 HUMPHREY RACHEL · CIK 0001579781 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,234 F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. Read SEC document |
| March 02, 2018 Filed Mar 5, 2018 23:59 UTC |
HUMPHREY RACHELChief Medical Officer
|
Exercise / conversionCommon Stock | 16,160 | $6.61 | $106,893.55 |
DisclosureSEC source: 0001140361-18-012113 · doc1.xml · nonDerivative · entry 1 HUMPHREY RACHEL · CIK 0001579781 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,394 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2018 Filed Mar 5, 2018 21:56 UTC |
RAY DEBANJANChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 14,485 | $0.00 Strike: $1.13 | $0.00 |
DisclosureSEC source: 0001140361-18-012009 · doc1.xml · derivative · entry 10 RAY DEBANJAN · CIK 0001706863 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 14,485 shares Expires 2021-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: 100% of the shares subject to the option are fully vested and exercisable. Read SEC document |
| March 02, 2018 Filed Mar 5, 2018 21:56 UTC |
RAY DEBANJANChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,515 | $0.00 Strike: $1.26 | $0.00 |
DisclosureSEC source: 0001140361-18-012009 · doc1.xml · derivative · entry 9 RAY DEBANJAN · CIK 0001706863 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,710 Underlying: Common Stock · 5,515 shares Expires 2023-12-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: 100% of the shares subject to the option are fully vested and exercisable. Read SEC document |
| March 02, 2018 Filed Mar 5, 2018 21:56 UTC |
RAY DEBANJANChief Financial Officer
|
SaleCommon Stock | 1,944 | $31.02 | $60,293.16 |
DisclosureSEC source: 0001140361-18-012009 · doc1.xml · nonDerivative · entry 7 RAY DEBANJAN · CIK 0001706863 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,741 F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $31.00 to $31.09, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| March 02, 2018 Filed Mar 5, 2018 21:56 UTC |
RAY DEBANJANChief Financial Officer
|
SaleCommon Stock | 12,541 | $30.41 | $381,384.35 |
DisclosureSEC source: 0001140361-18-012009 · doc1.xml · nonDerivative · entry 6 RAY DEBANJAN · CIK 0001706863 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,685 F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.99, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| March 02, 2018 Filed Mar 5, 2018 21:56 UTC |
RAY DEBANJANChief Financial Officer
|
Exercise / conversionCommon Stock | 14,485 | $1.13 | $16,424.54 |
DisclosureSEC source: 0001140361-18-012009 · doc1.xml · nonDerivative · entry 5 RAY DEBANJAN · CIK 0001706863 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,226 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2018 Filed Mar 5, 2018 21:56 UTC |
RAY DEBANJANChief Financial Officer
|
SaleCommon Stock | 5,515 | $30.06 | $165,775.39 |
DisclosureSEC source: 0001140361-18-012009 · doc1.xml · nonDerivative · entry 4 RAY DEBANJAN · CIK 0001706863 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,741 F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.38, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| March 02, 2018 Filed Mar 5, 2018 21:56 UTC |
RAY DEBANJANChief Financial Officer
|
Exercise / conversionCommon Stock | 5,515 | $1.26 | $6,948.35 |
DisclosureSEC source: 0001140361-18-012009 · doc1.xml · nonDerivative · entry 3 RAY DEBANJAN · CIK 0001706863 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,256 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:56 UTC |
RAY DEBANJANChief Financial Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 13,000 | $0.00 Strike: $1.26 | $0.00 |
DisclosureSEC source: 0001140361-18-012009 · doc1.xml · derivative · entry 8 RAY DEBANJAN · CIK 0001706863 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,225 Underlying: Common Stock · 13,000 shares Expires 2023-12-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: 100% of the shares subject to the option are fully vested and exercisable. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:56 UTC |
RAY DEBANJANChief Financial Officer
|
SaleCommon Stock | 13,000 | $29.40 | $382,241.60 |
DisclosureSEC source: 0001140361-18-012009 · doc1.xml · nonDerivative · entry 2 RAY DEBANJAN · CIK 0001706863 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,741 F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.81, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:56 UTC |
RAY DEBANJANChief Financial Officer
|
Exercise / conversionCommon Stock | 13,000 | $1.26 | $16,378.70 |
DisclosureSEC source: 0001140361-18-012009 · doc1.xml · nonDerivative · entry 1 RAY DEBANJAN · CIK 0001706863 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,741 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:55 UTC |
McCarthy Sean A.Director · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 62 | $0.00 Strike: $0.95 | $0.00 |
DisclosureSEC source: 0001140361-18-012008 · doc1.xml · derivative · entry 8 McCarthy Sean A. · CIK 0001654058 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,752 Underlying: Common Stock · 62 shares Expires 2023-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 100% of the shares subject to the option are fully vested and exercisable. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:55 UTC |
McCarthy Sean A.Director · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 9,000 | $0.00 Strike: $1.13 | $0.00 |
DisclosureSEC source: 0001140361-18-012008 · doc1.xml · derivative · entry 7 McCarthy Sean A. · CIK 0001654058 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 328,143 Underlying: Common Stock · 9,000 shares Expires 2021-09-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 100% of the shares subject to the option are fully vested and exercisable. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:55 UTC |
McCarthy Sean A.Director · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,516 | $0.00 Strike: $1.57 | $0.00 |
DisclosureSEC source: 0001140361-18-012008 · doc1.xml · derivative · entry 6 McCarthy Sean A. · CIK 0001654058 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,804 Underlying: Common Stock · 10,516 shares Expires 2025-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option vests in 48 substantially equal monthly installments starting on the last day of January 2015. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:55 UTC |
McCarthy Sean A.Director · President and CEO
|
SaleCommon Stock | 19,578 | $29.43 | $576,141.38 |
DisclosureSEC source: 0001140361-18-012008 · doc1.xml · nonDerivative · entry 4 McCarthy Sean A. · CIK 0001654058 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,643 F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.90, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:55 UTC |
McCarthy Sean A.Director · President and CEO
|
Exercise / conversionCommon Stock | 62 | $0.95 | $58.59 |
DisclosureSEC source: 0001140361-18-012008 · doc1.xml · nonDerivative · entry 3 McCarthy Sean A. · CIK 0001654058 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,221 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:55 UTC |
McCarthy Sean A.Director · President and CEO
|
Exercise / conversionCommon Stock | 9,000 | $1.13 | $10,205.10 |
DisclosureSEC source: 0001140361-18-012008 · doc1.xml · nonDerivative · entry 2 McCarthy Sean A. · CIK 0001654058 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,159 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:55 UTC |
McCarthy Sean A.Director · President and CEO
|
Exercise / conversionCommon Stock | 10,516 | $1.57 | $16,561.65 |
DisclosureSEC source: 0001140361-18-012008 · doc1.xml · nonDerivative · entry 1 McCarthy Sean A. · CIK 0001654058 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,159 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 11:54 UTC |
GLUCK FREDERICK WDirector
|
SaleCommon Stock | 3,819 | $30.00 | $114,570.00 |
DisclosureSEC source: 0001140361-18-011514 · doc1.xml · nonDerivative · entry 1 GLUCK FREDERICK W · CIK 0001184126 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Frederick W. Gluck 1997 Family Trust dtd July 28, 1997 Disclosed balance after: 292,824 F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · ownership.nature: The Reporting Person is a trustee of Frederick W. Gluck 1997 Family Trust dtd July 28, 1997. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 16:55 UTC |
HUMPHREY RACHELChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 23,840 | $0.00 Strike: $6.61 | $0.00 |
DisclosureSEC source: 0001140361-18-011515 · doc1.xml · derivative · entry 3 HUMPHREY RACHEL · CIK 0001579781 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,140 Underlying: Common Stock · 23,840 shares Expires 2025-08-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option vests 25% on August 28, 2016, and the remaining 75% vests in 36 substantially equal monthly installments thereafter, with each additional installment vesting on the last day of the month, except the final installment, which shall vest on August 28, 2019. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 16:55 UTC |
HUMPHREY RACHELChief Medical Officer
|
SaleCommon Stock | 23,840 | $30.00 | $715,200.00 |
DisclosureSEC source: 0001140361-18-011515 · doc1.xml · nonDerivative · entry 2 HUMPHREY RACHEL · CIK 0001579781 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,234 F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 16:55 UTC |
HUMPHREY RACHELChief Medical Officer
|
Exercise / conversionCommon Stock | 23,840 | $6.61 | $157,694.45 |
DisclosureSEC source: 0001140361-18-011515 · doc1.xml · nonDerivative · entry 1 HUMPHREY RACHEL · CIK 0001579781 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,074 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2018 Filed Feb 3, 2018 00:28 UTC |
RAY DEBANJANChief Financial Officer
|
SaleCommon Stock | 2,548 | $26.69 | $68,009.94 |
DisclosureSEC source: 0001140361-18-004851 · doc1.xml · nonDerivative · entry 1 RAY DEBANJAN · CIK 0001706863 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,741 F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $26.39 to $27.19, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| January 24, 2018 Filed Jan 26, 2018 21:52 UTC |
HUMPHREY RACHELChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $25.82 | $0.00 |
DisclosureSEC source: 0001140361-18-003419 · doc1.xml · derivative · entry 1 HUMPHREY RACHEL · CIK 0001579781 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2028-01-23 F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from January 1, 2018 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date. Read SEC document |
| January 24, 2018 Filed Jan 26, 2018 19:55 UTC |
RAY DEBANJANChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $25.82 | $0.00 |
DisclosureSEC source: 0001140361-18-003376 · doc1.xml · derivative · entry 1 RAY DEBANJAN · CIK 0001706863 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2028-01-23 F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from January 1, 2018 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date. Read SEC document |
| January 24, 2018 Filed Jan 26, 2018 19:54 UTC |
Kavanaugh William MichaelCSO, Head Res.&Non-Clin. Dev.
|
GrantStock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $25.82 | $0.00 |
DisclosureSEC source: 0001140361-18-003375 · doc1.xml · derivative · entry 1 Kavanaugh William Michael · CIK 0001578767 · CSO, Head Res.&Non-Clin. Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2028-01-23 F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from January 1, 2018 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date. Read SEC document |
| January 24, 2018 Filed Jan 26, 2018 19:53 UTC |
McCarthy Sean A.Director · President and CEO
|
GrantStock Option (right to buy) · Derivative | 300,000 | $0.00 Strike: $25.82 | $0.00 |
DisclosureSEC source: 0001140361-18-003373 · doc1.xml · derivative · entry 1 McCarthy Sean A. · CIK 0001654058 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2028-01-23 F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from January 1, 2018 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date. Read SEC document |
| January 05, 2018 Filed Jan 8, 2018 17:47 UTC |
GLUCK FREDERICK WDirector
|
SaleCommon Stock | 10,000 | $25.01 | $250,078.00 |
DisclosureSEC source: 0001140361-18-001261 · doc1.xml · nonDerivative · entry 1 GLUCK FREDERICK W · CIK 0001184126 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Frederick W. Gluck 1997 Family Trust dtd July 28, 1997 Disclosed balance after: 296,643 F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.21, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F3 · ownership.nature: The Reporting Person is a trustee of Frederick W. Gluck 1997 Family Trust dtd July 28, 1997. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 16:20 UTC |
McCarthy Sean A.Director · President and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 6,526 | $0.00 Strike: $1.13 | $0.00 |
DisclosureSEC source: 0001140361-18-001360 · doc1.xml · derivative · entry 4 McCarthy Sean A. · CIK 0001654058 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 337,143 Underlying: Common Stock · 6,526 shares Expires 2021-09-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 100% of the shares subject to the option are fully vested and exercisable. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.